🇺🇸 FDA
Patent

US 11400063

Early administration of low-dose colchicine after myocardial infarction

granted A61KA61K31/165A61P

Quick answer

US patent 11400063 (Early administration of low-dose colchicine after myocardial infarction) held by INSTITUT DE CARDIOLOGIE DE MONTREAL expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INSTITUT DE CARDIOLOGIE DE MONTREAL
Grant date
Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
50
CPC classes
A61K, A61K31/165, A61P, A61P9/10